<?xml version="1.0" encoding="UTF-8"?>
<p>Stem cell mobilization and collection was performed as described previously 
 <xref rid="sct312271-bib-0004" ref-type="ref">4</xref>. In short, stem cells were mobilized by daily subcutaneous injections of G‚ÄêCSF (10 mcg/kg daily, 5 days). Peripheral blood stem cells were collected with Amicus Separator System (Fenwal Inc., Lake Zurich, IL, 
 <ext-link ext-link-type="uri" xlink:href="http://www.fresenius-kabi.com" xmlns:xlink="http://www.w3.org/1999/xlink">http://www.fresenius-kabi.com</ext-link>), and the magnetic cell separator Clinimacs (Miltenyi Biotec, Germany, 
 <ext-link ext-link-type="uri" xlink:href="http://www.miltenyibiotec.com" xmlns:xlink="http://www.w3.org/1999/xlink">http://www.miltenyibiotec.com</ext-link>) was used for the imunomagnetic positive selection of CD34
 <sup>+</sup> cells. Of the recovered CD34
 <sup>+</sup> cells, 80 million were used for transendocardial injection.
</p>
